Coronavirus vaccine supply has become a critical issue as nations seek to stem high infection rates. Last week, AstraZeneca told the EU it was falling behind on its supply target because of production problems. U.S. pharmaceutical Pfizer/Biontech proceeded to temporary cut deliveries while cases in many European countries surge.
From its side, the European Union warned it will tighten exports of Covid vaccines produced in the bloc. Competitions, delays, exports' restrictions, business profits are putting people's health into risk.